Top 3 Most Read CRO/Sponsor Feature Articles of 2023

Image Credit: © lidiia - stock.adobe.com

Below is a list of the most read CRO/sponsor articles featured on Applied Clinical Trials in 2023.

1. COVID-19 Pandemic Exemplifies the Benefits of CROs

Clinical research is necessary for the development of new health products. The evaluation of the safety and efficacy of new drugs or devices in patients is already governed by numerous regulations. Furthermore, speed requirements and competition between the various pharmaceutical and biotech companies are also factors in the dynamics of the industry. All these aspects intensified during the outbreak of the COVID-19 pandemic which was an opportunity to exemplify the unique role that CROs play in clinical research due to their expertise and ability to rapidly adapt and respond to a changing environment.

Read the full article here.

2. Outsourcing Model Usage and its Relationship to Clinical Trial Performance

Tufts Center for the Study of Drug Development (CSDD) and ICON plc proposed a new framework to differentiate sourcing models based on type of contract services. Rather than using traditional definitions this novel approach uses the CRO’s infrastructure and processes for clinical trial conduct resulting in mixed models and combinations of sourcing models. The development of this classification is based on the following factors: outsourcing orientation, infrastructure support, and accountability or contracting structure.

Read the full article here.

3. Harmonizing Outsourcing to Keep Clinical Trials on Track

In the past decade, the clinical research industry has experienced a proliferation of new outsourcing models and operational strategies in which CROs and sponsors are working in more integrated ways. Against the background of the increasingly complex clinical research landscape, we have seen a rise in strategic partnerships and partnership-driven approaches to outsourcing as a way to navigate that complexity and more effectively deliver clinical trials.

Now more than ever, developing a shared partnership culture is important to support the more complex strategic objectives and operative functions that keep clinical trials humming.

Read the full article here.